Levamisole treatment of recurrent spastic bronchitis in children--the effect on selected parameters of immunologic and hemostatic systems.
20 children suffering from spastic bronchitis were treated with levamisole, given for 3 consecutive days in two following weeks. Full therapeutic effect was obtained in 16 children and partial effect in 1 child. The clinical improvement was accompanied by an increase of peripheral T lymphocyte number. No significant side effects were observed.
D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D001991:Bronchitis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007223:Infant; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
D007136:Immunoglobulins; D007978:Levamisole